{
  "main_header": {
    "sid": 10039112,
    "name": "Innova Captab",
    "stock_name": "Innova Captab",
    "full_name": "Innova Captab Ltd",
    "name_url": "stocks-analysis/innova-captab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "706.00",
    "chg": -2.85,
    "chgp": "-0.4%",
    "dir": -1,
    "prev_price": "708.85",
    "mcapval": "4,041.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544067",
    "symbol": "INNOVACAP",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0DUT01020",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "6.51 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/innova-captab-10039112-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Innova Captab Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-technical-momentum-shifts-amid-prolonged-downtrend-3740475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/InnovaCaptab_technicaldot_3740475.png",
        "date": "2025-12-02 08:13:25",
        "description": "Innova Captab, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments reflect a transition from bearish to mildly bearish trends. Despite a subdued price movement, the stock’s technical indicators present a complex picture that investors and analysts are closely monitoring amid broader market dynamics."
      },
      {
        "title": "How has been the historical performance of Innova Captab?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-innova-captab-3739421",
        "imagepath": "",
        "date": "2025-12-01 23:42:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Over the fiscal years ending March 2023 to March 2025, Innova Captab’s net sales have shown a steady increase, rising from ₹926.38 crores in March 2023 to ₹1,243.68 crores in March 2025. This represents a compound growth trend reflecting the company’s expanding market presence and sales capabilities. Correspondingly, the total operating income mirrored this growth, with no other operating income reported during this period.</p>\n<p>The company’s operating profit before depreciation, interest, and tax (PBDIT) also improved significantly, climbing from ₹122.85 crores in March 2023 to ₹198.21 crores in March 2025. This increase was supported by a rising operating profit margin, which expanded from 12.27% to 14.97%, indicating enhanced operational efficie..."
      },
      {
        "title": "Innova Captab's Evaluation Metrics Revised Amidst Challenging Market Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3735242",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/InnovaCaptab_mojoScore_3735242.png",
        "date": "2025-11-28 10:05:12",
        "description": "Innova Captab has experienced a revision in its evaluation metrics reflecting recent financial and technical developments. The pharmaceutical and biotechnology small-cap company’s assessment now signals a more cautious market outlook, influenced by its operational results and stock performance trends."
      },
      {
        "title": "Innova Captab Hits Intraday High with Strong Trading Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-hits-intraday-high-with-849-surge-on-25-nov-2025-3728142",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/InnovaCaptab_priceRelatedfactors_3728142.png",
        "date": "2025-11-25 09:43:01",
        "description": "Innova Captab recorded a notable surge today, touching an intraday high of Rs 791.25, reflecting a gain of 8.49% amid heightened volatility and active trading. This performance stands out despite the stock’s recent downward trend over the past two sessions."
      },
      {
        "title": "Why is Innova Captab falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-innova-captab-fallingrising-3703595",
        "imagepath": "",
        "date": "2025-11-15 00:06:33",
        "description": "As of 14-Nov, Innova Captab Ltd's stock price is currently at 752.00, reflecting an increase of 22.05 (3.02%). The stock has shown a positive trend recently, gaining for the last two days with a total return of 6.15% during this period. Despite this short-term gain, the stock has underperformed over the longer term, with a 1-month return of -9.77% and a year-to-date return of -31.88%. The stock is trading at a discount compared to its peers, supported by a low Debt to EBITDA ratio of 1.40 times and a return on capital employed (ROCE) of 12.4. However, the company has faced challenges, including a significant decline in investor participation, as evidenced by a 42.52% drop in delivery volume against the 5-day average.\n\nBroader market context indicates that while Innova Captab has outperformed its sector by 2.65% today, it has lagged behind the benchmark Sensex, which has gained 1.62% over the past week. The ..."
      },
      {
        "title": "Why is Innova Captab falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-innova-captab-fallingrising-3687425",
        "imagepath": "",
        "date": "2025-11-11 00:19:42",
        "description": "As of 10-Nov, Innova Captab Ltd's stock price is currently at Rs 738.40, reflecting a decline of Rs 29.35 or 3.82%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total drop of 10.6% during this period. It opened with a loss of 2.31% today and reached an intraday low of Rs 738.40. Over the past week, the stock has decreased by 9.04%, and its year-to-date performance shows a significant decline of 33.12%. Despite a strong ability to service debt and attractive valuations compared to peers, the stock's recent performance is negatively impacted by flat results in the latest quarter, including a decrease in profit after tax and consistent underperformance against benchmarks over the last three years.\n\nIn the broader market context, the Sensex has only declined by 0.53% over the past week, indicating that Innova Captab's performance is significantly worse ..."
      },
      {
        "title": "Are Innova Captab latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-innova-captab-latest-results-good-or-bad-3682504",
        "imagepath": "",
        "date": "2025-11-08 19:23:17",
        "description": "Innova Captab's latest financial results for the September 2025 quarter reveal a complex picture characterized by strong revenue growth juxtaposed with declining profitability. The company reported net sales of ₹380.38 crores, achieving a year-on-year increase of 19.54% and a quarter-on-quarter growth of 8.20%. This marks a record high for the company, indicating robust demand across its product segments.\n\nHowever, this top-line momentum is overshadowed by significant challenges on the bottom line. The net profit for the quarter fell to ₹29.67 crores, reflecting a decline of 15.23% year-on-year and a decrease of 4.35% from the previous quarter. The profit after tax (PAT) margin also contracted to 7.80%, down from 8.82% in the prior quarter, indicating a 102 basis points decline. This erosion of margins raises concerns about the company's ability to sustain profitability amid rising operational costs, includ..."
      },
      {
        "title": "Innova Captab Q2 FY26: Profit Decline Amid Revenue Growth Signals Margin Pressure",
        "link": "https://www.marketsmojo.com/news/result-analysis/innova-captab-q2-fy26-profit-decline-amid-revenue-growth-signals-margin-pressure-3680921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/InnovaCaptab_quaterlyResult_3680921.png",
        "date": "2025-11-07 21:49:37",
        "description": "Innova Captab Limited, a small-cap pharmaceutical manufacturer with a market capitalisation of ₹4,589 crores, reported mixed quarterly results for Q2 FY26, with net profit declining 4.35% quarter-on-quarter to ₹29.67 crores despite revenue growth of 8.20%. The company's shares tumbled 4.65% on November 7, closing at ₹764.25, reflecting investor concerns over deteriorating profitability metrics and persistent margin compression that has plagued the company's recent performance."
      },
      {
        "title": "Is Innova Captab overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-innova-captab-overvalued-or-undervalued-3678150",
        "imagepath": "",
        "date": "2025-11-07 08:13:08",
        "description": "As of 6 November 2025, Innova Captab has moved from a fair to attractive valuation grade, indicating a more favorable outlook. The company is currently considered undervalued. Key ratios include a PE ratio of 35.54, an EV to EBITDA of 24.91, and a PEG ratio of 0.99, which suggests that the stock is priced reasonably relative to its growth potential.\n\nIn comparison to its peers, Innova Captab's PE ratio is higher than Sun Pharma's 35.02 but lower than Divi's Lab's significantly high 79.09, indicating a competitive position within the industry. Additionally, while Cipla has a more attractive PE of 22.27, Innova Captab's PEG ratio of 0.99 suggests it offers better growth at its current price. Despite recent underperformance against the Sensex, with a year-to-date return of -26.98% compared to the Sensex's 6.62%, the valuation metrics support a bullish outlook for the stock moving forward...."
      }
    ],
    "total": 468,
    "sid": "10039112",
    "stock_news_url": "https://www.marketsmojo.com/news/innova-captab-10039112"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "15-Nov-2025",
      "details": "Pursuant to the Regulation 30 read with Schedule III Part A - Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the officials of the Company will be attending the Investor Conference scheduled to be held on Friday 21 November 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "13-Nov-2025",
      "details": "Transcript of the Investor/Analyst Earnings Call held on 10th November 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "10-Nov-2025",
      "details": "Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) - Audio Recording of Earnings Call - Quarter and half year ended 30th September 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Innova Captab Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:13:25

Innova Captab, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments reflect a transition from bearish to mildly bearish trends. Despite a subdued price movement, the stock’s technical indicators present a complex picture that investors and analysts are closely monitoring amid broader market dynamics.

Read More

How has been the historical performance of Innova Captab?

2025-12-01 23:42:18

Revenue and Profit Growth

Over the fiscal years ending March 2023 to March 2025, Innova Captab’s net sales have shown a steady increase, rising from ₹926.38 crores in March 2023 to ₹1,243.68 crores in March 2025. This represents a compound growth trend reflecting the company’s expanding market presence and sales capabilities. Correspondingly, the total operating income mirrored this growth, with no other operating income reported during this period.

The company’s operating profit before depreciation, interest, and tax (PBDIT) also improved significantly, climbing from ₹122.85 crores in March 2023 to ₹198.21 crores in March 2025. This increase was supported by a rising operating profit margin, which expanded from 12.27% to 14.97%, indicating enhanced operational efficie...

Read More

Innova Captab's Evaluation Metrics Revised Amidst Challenging Market Performance

2025-11-28 10:05:12

Innova Captab has experienced a revision in its evaluation metrics reflecting recent financial and technical developments. The pharmaceutical and biotechnology small-cap company’s assessment now signals a more cautious market outlook, influenced by its operational results and stock performance trends.

Read More

Innova Captab Hits Intraday High with Strong Trading Momentum

2025-11-25 09:43:01

Innova Captab recorded a notable surge today, touching an intraday high of Rs 791.25, reflecting a gain of 8.49% amid heightened volatility and active trading. This performance stands out despite the stock’s recent downward trend over the past two sessions.

Read More

Why is Innova Captab falling/rising?

2025-11-15 00:06:33

As of 14-Nov, Innova Captab Ltd's stock price is currently at 752.00, reflecting an increase of 22.05 (3.02%). The stock has shown a positive trend recently, gaining for the last two days with a total return of 6.15% during this period. Despite this short-term gain, the stock has underperformed over the longer term, with a 1-month return of -9.77% and a year-to-date return of -31.88%. The stock is trading at a discount compared to its peers, supported by a low Debt to EBITDA ratio of 1.40 times and a return on capital employed (ROCE) of 12.4. However, the company has faced challenges, including a significant decline in investor participation, as evidenced by a 42.52% drop in delivery volume against the 5-day average. Broader market context indicates that while Innova Captab has outperformed its sector by 2.65% today, it has lagged behind the benchmark Sensex, which has gained 1.62% over the past week. The ...

Read More

Why is Innova Captab falling/rising?

2025-11-11 00:19:42

As of 10-Nov, Innova Captab Ltd's stock price is currently at Rs 738.40, reflecting a decline of Rs 29.35 or 3.82%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total drop of 10.6% during this period. It opened with a loss of 2.31% today and reached an intraday low of Rs 738.40. Over the past week, the stock has decreased by 9.04%, and its year-to-date performance shows a significant decline of 33.12%. Despite a strong ability to service debt and attractive valuations compared to peers, the stock's recent performance is negatively impacted by flat results in the latest quarter, including a decrease in profit after tax and consistent underperformance against benchmarks over the last three years. In the broader market context, the Sensex has only declined by 0.53% over the past week, indicating that Innova Captab's performance is significantly worse ...

Read More

Are Innova Captab latest results good or bad?

2025-11-08 19:23:17

Innova Captab's latest financial results for the September 2025 quarter reveal a complex picture characterized by strong revenue growth juxtaposed with declining profitability. The company reported net sales of ₹380.38 crores, achieving a year-on-year increase of 19.54% and a quarter-on-quarter growth of 8.20%. This marks a record high for the company, indicating robust demand across its product segments. However, this top-line momentum is overshadowed by significant challenges on the bottom line. The net profit for the quarter fell to ₹29.67 crores, reflecting a decline of 15.23% year-on-year and a decrease of 4.35% from the previous quarter. The profit after tax (PAT) margin also contracted to 7.80%, down from 8.82% in the prior quarter, indicating a 102 basis points decline. This erosion of margins raises concerns about the company's ability to sustain profitability amid rising operational costs, includ...

Read More

Innova Captab Q2 FY26: Profit Decline Amid Revenue Growth Signals Margin Pressure

2025-11-07 21:49:37

Innova Captab Limited, a small-cap pharmaceutical manufacturer with a market capitalisation of ₹4,589 crores, reported mixed quarterly results for Q2 FY26, with net profit declining 4.35% quarter-on-quarter to ₹29.67 crores despite revenue growth of 8.20%. The company's shares tumbled 4.65% on November 7, closing at ₹764.25, reflecting investor concerns over deteriorating profitability metrics and persistent margin compression that has plagued the company's recent performance.

Read More

Is Innova Captab overvalued or undervalued?

2025-11-07 08:13:08

As of 6 November 2025, Innova Captab has moved from a fair to attractive valuation grade, indicating a more favorable outlook. The company is currently considered undervalued. Key ratios include a PE ratio of 35.54, an EV to EBITDA of 24.91, and a PEG ratio of 0.99, which suggests that the stock is priced reasonably relative to its growth potential. In comparison to its peers, Innova Captab's PE ratio is higher than Sun Pharma's 35.02 but lower than Divi's Lab's significantly high 79.09, indicating a competitive position within the industry. Additionally, while Cipla has a more attractive PE of 22.27, Innova Captab's PEG ratio of 0.99 suggests it offers better growth at its current price. Despite recent underperformance against the Sensex, with a year-to-date return of -26.98% compared to the Sensex's 6.62%, the valuation metrics support a bullish outlook for the stock moving forward....

Read More

View All News